2020 Revenues ($USD) : $3,062,268,000
2020 Revenues (foreign currencies) : €2,686,200,000
2020 R&D spend : $461,700,000
2020 Number of Employees : 5,700
Fiscal Year End : 12/31/2020
Key People : David Loew, CEO

Ipsen is a mid-size biopharmaceutical company focusing on transformative medicines in oncology, rare diseases and neuroscience. It markets more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen has located its R&D in major biotech and life sciences hubs, including Paris-Saclay in France; Oxford, U.K.; Cambridge, Mass.; and Shanghai. –CN